Mar 28 2022 Recardio at BIO-Europe Spring 2022 San Francisco, March 28, 2022 – Recardio Inc., a late stage clinical-stage life science company focusing on regenerative therapies for cardiovascular diseases, is participating at the BIO-Europe Spring 2022. Read More